Examination Report |
1 | Power of Attorney | 11 Nov 2010 |
10 | Hearing Notice | 24 Oct 2016 |
11 | Abandoned Notice | 27 Oct 2016 |
12 | Journal Copy | 07 Nov 2016 |
13 | Return post | 31 Jan 2017 |
14 | Certificate | 30 Mar 2017 |
15 | TM-R(RENEWAL OF TRADE MARK) | 20 Nov 2020 |
2 | Reply to Exam Report (MIS-R) | 17 May 2012 |
3 | Authorization Document (POA) | 18 May 2012 |
4 | TM-16 | 18 May 2012 |
5 | Authorization Letter | 22 Oct 2013 |
6 | Other Documents | 16 Jun 2016 |
7 | TM-16 | 22 Oct 2016 |
8 | Hearing Notice | 24 Oct 2016 |
9 | Affidavit | 24 Oct 2016 |
1 | Tribunal ABA Notice for : 2052521 | 4157073 | 27 Oct 2016 | |
2 | O3 NOTICE | 10509690 | 5004169 | 06 Oct 2020 |
3 | RENEWAL INTIMATION LETTER | 10719249 | 23 Nov 2020 |
Trademark was applied on 11 November 2010 with IP India.
Proprietor of Scellcare is TranScell Biologics Private Limited.
Class(es) in which the trademark was applied to is 44.
Status of Scellcare is Registered.
Application number alloted to the trademark is 2052521.
Tempus Law Associates is the Trademark agent/attorney.
Trademark has been filed in the following category:
DEVICE